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Ethical Regulation of Medical
Experiments on Humans
BY NICK AWERTSCHENKO ’21
Figure 1: A doctor draws blood
from one of the Tuskegee test
subjects.
Source: Wikimedia Commons
(Credit: National Archives)
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Ethics should always be the primary
concern regarding any research that involves
human experimentation. Yet, in the Tuskegee
Study (1), we see the consequences of 40 years of
unregulated human experimentation violating
any degree of ethical standards. This experiment
was unethical from the start, as the potential
knowledge that could have been gained from
the experiment would not have been useful
in treating patients in the future; all the
experiment accomplished was risking the lives
of and causing immense suffering to hundreds
of patients with no possible medical benefit.
Furthermore, the experiment completely lacked
informed consent and instead, the Public Health
Service or PHS (1) took advantage of the racial
and socioeconomic status of the Macon County
community to manipulate the uneducated
population into agreeing to the study. Once
word of the study spread throughout the
scientific community, a few critics brought the
moral and scientific flaws to light. However,
since the study was regulated by the PHS,
which was the same organization running the

study staffed by members who had been part
of the study for years, these major problems
were overlooked, and the study was allowed to
continue for many decades. These major aspects
of the Tuskegee study demonstrate the need for
serious ethical regulation regarding any medical
study regarding humans and provide insight on
how this should be done in the future.
Opinion concerning the ethics of
the Tuskegee experiment and human
experimentation in general varies drastically,
which is part of why universal ethical standards
are difficult to define. Some experts defend the
Tuskegee experiment from an ethical standpoint
and justify withholding treatment of syphilis
with the other types of medical care patients got
instead and the risky nature of chemotherapy in
the early years. Nurse Eunice Rivers, who was
directly involved with bridging the gap between
doctors and patients, justifies withholding
treatment by claiming that the harmful effects of
the early treatment were too severe, and that the
patients received many other medical benefits
to compensate for their lack of treatment.
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She says, “I saw so many reactions with these
medications[Neoarsphenamine and bismuth]…
I didn’t feel good about neo and all this stuff ”
(1). As James Jones, the author of Bad Blood,
states, even if Nurse Rivers truly believed in this
justification due to the potentially harmful side
effects of early treatment, the argument falls
apart when applied to withholding penicillin.
In order to rationalize the later years of her
involvement in the study, Rivers states, “They
didn’t get treatment for syphilis, but they got so
much else,” referring to the medical care they got
from doctors regularly checking up on them and
giving them free aspirin and “spring tonic” for
their aches and pains (1). Dr. Heller, who was Dr.
Vonderlehr’s successor as director of Division of
Venereal Diseases, justifies continuing the study
even with the advent of penicillin by stating
“The longer the study, the better the ultimate
information we would derive,” and looking back
he does feel that the experiment was unethical
but also believes it is not comparable to the
Nuremberg trials (1).
On the other side of the spectrum, many
experts believe that the Tuskegee study was
immoral and have different notions of what
makes a human experiment ethical. The first
doctor to object to the ethics of the study was
Dr. Irwin J. Schatz of Henry Ford Hospital
who sent a letter to the author of an article
on the study saying, “I am utterly astounded
by the fact that physicians allow patients with
a potentially fatal disease to remain untreated
when effective therapy is available… I suggest
that the[PHS doctors]… reevaluate their
moral judgements…” (1). Schatz expresses his
disapproval of withholding treatment from the
men in the study due to moral concerns and
was the first to do so by 1965, 23 years after the
study begun. Another expert who opposes the
study is Peter Buxtun, an investigator born to
parents who fled Europe from the Nazis. Due
to his background, Buxtun was able to draw
the connection between the Nuremberg trials
of the Nazis to the Tuskegee experiment and
expressed to coworkers that “It [the Tuskegee
study] didn’t sound like what a PHS institution
should be doing” (1). Buxtun expressed “grave
moral concerns about the experiment” and
pointed out the lack of informed consent by
saying, “they were nothing more than dupes
and were being used as human substitutes for
guinea pigs” (1). Many modern experts also have
similar opinions on human studies in general,
including Dr. Marcia Angell, executive editor
of The New England Journal of Medicine, and
Marc Lallemant, an investigator from Harvard,
who openly express their opinions against using
“dummy pills” for a more recent AIDS studies
in third world countries (2). The Physicians
Committee for Responsible Medicine (3) also
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emphasizes the importance of taking morality
seriously in any human experiment (3).
From the wide expert opinions on medical
ethics, I would agree with Dr. Schatz, Peter
Buxtun, and the Physicians Committee for
Responsible Medicine that the morality of
an experiment involving humans must be
considered seriously. I feel that Dr. Schatz and
Buxtun were completely correct for expressing
their concerns to the PHS even at the risk of their
careers, and that whistleblowers in the medical
community should be commended for their
actions. On the other hand, I completely disagree
with Nurse Rivers’ and Dr. Heller’s opinions on
the experiment, and I was disgusted by Heller’s
absolute disregard for the wellbeing of the
patients and Rivers’ delusional rationalization
that she was helping the men by conducting
the study. I believe that both Rivers and Heller
should have their medical licenses and awards
revoked due to their failure to practice medicine
ethically under the Hippocratic Oath-- this
would simultaneously serve as a form of justice
as well as set an example for future practitioners
of medicine. Regarding the placebo pills in third
world countries, I believe that their usage is
not nearly as unethical a practice as lying to
patients with a fatal disease about treatment,
but it should be required to test prototype
drugs against the current standards instead of
placebos. Since governments subsidize these
experiments in the third world, it should be
their responsibility to find the funding for
these tests instead of putting the burden on the
pharmaceutical companies.
In order to ameliorate the condition of
human medical research, I think that human
experimentation needs to be heavily regulated
to ensure that it is kept within the bounds of
current ethical standards. I would define these
standards to include a need for informed and
voluntary consent of the subjects, as well as
a clear potential benefit that could improve
humanity significantly enough to justify the
potential risks on the subjects. In order to create
and enforce these regulations, the government
may need to create an organization purely to
pass and enforce laws regarding this issue. This
organization should not engage in research
itself as this would make proper enforcement
of ethical standards impossible, which is exactly
what happened with the PHS’s attempt to
assess itself during the Tuskegee study. The
organization should be publicly open about its
actions in order to allow for the general public
to help determine what is ethical. This should
also be brought up to an international level so
that ethical standards can be kept consistent
across the globe.
The first step in attaining ethical standards
in medical experiments on humans is to define

“I was disgusted by
Heller’s absolute
disregard for
the wellbeing of
the patients and
Rivers’ delusional
rationalisation that
she was helping the
men by conducting
the study.”

“[The government
organization that
creates and enforces
regulations for
ethical research]
should be publicly
open about its
actions in order to
allow for the general
public to help
determine what is
ethical.”
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“History and
common sense
demonstrate that
leaving private
companies or
government
organizations to
regulate their own
research will not be
effective due to the
immense conflict
of interest that self
regulation creates.”

Figure 2: Subjects talking
with study coordinator, Nurse
Eunice Rivers c. 1970.
Source: Wikimedia Commons
(Credit: Center for Disease
Control and Prevention)
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those standards. From analyzing the flaws in
the Tuskegee study as well as the testimonials
of experts and non-experts, I have narrowed
down a few crucial factors that determine the
morality of a human experiment. The first is
that in order for an experiment to be ethical, its
risks must be justifiable by a potential benefit
for humanity greater than the risks it imposes
on the subjects. This should be common sense
since it is never ethical to harm other people
for no reason; however, the doctors conducting
the Tuskegee study seemed to have missed this
important checkpoint when assessing their
experiment. In the case of the Tuskegee study,
the scientific knowledge that could have been
gained was only for curiosity, as there was
no intention of coming up with an improved
cure from the study. Jones’ book puts it well
with the 12th chapter title: “Nothing Learned
Will Prevent, Find, or Cure a Single Case.” This
first qualification for an ethical study is also
supported by my personal communication
with peers, who also brought up the point that
humans should only be tested if it is for the
greater good of society. Moreover, the Physicians
Committee for Responsible Medicine also agrees
that any unnecessary experimentation should
be avoided, including testing for patents on new
drugs that are “essentially a copy of an existing
drug” (3).
A second requirement for meeting ethical

standards should be the voluntary and informed
consent of participants in the study. This means
that subjects of the experiment should not be
pressured to join or taken advantage of due
to their racial, socioeconomic, or any other
type of status. Instead, researchers should seek
volunteers who understand the risks of the
study and agree to partake in the study. This also
should be common sense since it is never ethical
to forcefully impose health risks on another
person without their agreement to it. Like the
first requirement, the need for informed consent
was also not met during the Tuskegee study, as
the uneducated, poor, and historically neglected
black population of Macon County was an
easy target for deceit. Similarly, the National
Academy of Sciences revealed in 1993 that the
U.S. military had been conducting chemical
weapons tests from 1944 to 1977 on thousands
of American GIs and radiation tests on over
two hundred thousand civilians all without
their informed consent (3). These practices are
not morally acceptable and call for the need
of informed consent. These two principles of
ethics must be taken into account whenever
conducting human experiments and should
be incorporated into legal policies governing
medical research.
Once regulatory policy is built based on
these requirements, a government organization
needs to be created to enforce these regulations
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and keep them up to date with current medical
practices. The government organization should
not conduct any research itself and should
remain completely unaffiliated with any
organization or company that does conduct
medical research. The reason for this is to ensure
that the medical research community can have
an unbiased governing body completely devoted
to maintaining the ethics of any experiments
being conducted. History and common sense
demonstrate that leaving private companies
or government organizations to regulate their
own research will not be effective due to the
immense conflict of interest that self regulation
creates. Looking back at the Tuskegee Study,
the PHS attempted to inspect itself by creating
an ad hoc counsel of its own members to
determine the flaws of their own study. Due
to the biases of the members and the potential
career consequences speaking out would entail,
no significant progress was made on seeing the
ethical problems. In modern medical research,
experiments on humans are required to follow
the Common Rule, which was made in 1991 and
“defined human participant research, specified
the role and scope of informed consent, and
required research oversight and compliance
through institutional review boards (IRBs) at
participating research entities.” In addition,
many government agencies were formed to help
regulate human research including the Office
for Human Research Protections (OHRP). These
steps that the government has taken in response
to Tuskegee are good progress; however, there is
still much room for improvement. For example,
a current problem with the policy is that it has
become out of date due to changes in medical
practices, so a new version of the law has been
passed and will take effect starting in 2018 (4).
The final step in ensuring that human medical
research is as ethical as possible is expanding
the scope of regulation to the public. I believe
that it is essential for the public to be involved
as educated observers in order to make sure that
both private companies as well as government
regulatory bodies are following ethical protocol.
In this way, the public serves as an additional
check on the government organizations. In
order to ensure that the public gets involved,
the government agencies must have a high
level of transparency and must work to spread
awareness of important ethical issues in human
research. One way this can be done is by using
correct terms when describing an experiment.
In a linguistics article, George Annas points out
that “Even a cursory examination of modern
human experimentation demonstrates the
pervasiveness of three doublespeak concepts:
experimentation is treatment, researchers are
physicians, and subjects are patients”(Elliot).
This demonstrates the power of the language
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used to describe human experiments; in modern
medical experiments, researchers market their
human experiment as a study to make it seem
harmless, as the term “study” has a much less
serious connotation than “human experiment”
does. In this way, researchers are able to deceive
many people into participating since they
overlook the risks once they have perceived it
as a harmless study.
Possible objections to the need for strong
regulation of an ethical standard in human
medical research include its questionable
practicality and whether regulation will be able
to keep up with changes in medical practices. The
first objection is reasonable since government
agencies are not infallible and do have a chance
of falling to corruption and bribery by large
pharmaceutical companies. In order to mitigate
this risk, these regulatory government agencies
should be very open to the public about their
actions in order to allow the general population
to act as a check and balance. Another objection
stems from the possibility of companies
outsourcing human experimentation to overseas
outside of U.S. regulatory bodies’ jurisdiction.
For this reason, I think it is important to add
informed consent on human experimentation to
the list of basic human rights that the United
Nations protects in order to have international
compliance with ethical standards. Finally, there
is the issue of changes in medical practices due
to accelerating globalization and technological
growth outpacing regulation. This concern is
valid and is a major problem across all types
of government regulation. The best solution to
this would be to adhere to the general principles
of ethics at all times so that even when specific
regulation laws become obsolete due to new
procedures and technology, experimentation is
still bound by the basic foundation of ethics.
The importance of regulation on human
medical experiments is incontrovertible due
to the story that the history tells us of the
consequences of unregulated or under-regulated
human experimentation. If adequate regulation
is not implemented, repeats of Tuskegee,
chemical weapons tests, radiation tests, AIDS
placebo tests, and many more of the type are
certain to occur. Therefore, it is important to set
up the rules in such a way that pharmaceutical
companies are incentivized to conduct only
ethical research with the informed consent
of the subjects and the potential benefits to
humanity in mind. In order to implement
these rules, a new government organization
should be created with the purpose of keeping
experiments in check legally. This organization
would differ from current organizations since it
would be connected to the legal department and
be overseen by the attorney general. This would
ensure that this regulatory organization will have

“It is important to
set up the rules
in such a way that
pharmaceutical
companies are
incentivized to
conduct only ethical
research with the
informed consent of
the subjects and the
potential benefits to
humanity in mind.”
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“Polyheme changed
the course of their
study and in the
process, lost the
informed consent
that was originally
part of the study
and cost the lives of
many patients who
were unwillingly
subject to the study.”

legal jurisdiction to enforce federal regulations
at any time during the study. This is opposed
to the current Institutional Review Boards that
are in place and only determine if a study can
begin according to the guidelines set by the
institution. A federal legal organization could
also conduct random reviews mid-experiment
for a certain percent of human experiments
conducted in the country. The reason this is an
important improvement from IRBs is because
oftentimes a study will change its course as
it goes on, escaping the regulation of IRBs,
which only check the study at its inception. A
recent example of this is the Polyheme testing,
which was a test for a substitute for blood
transfusions during emergency situations. The
study started out by following informed consent
standards; however, this changed as the study
went on. An article on the ethics of this study
states, “Trialing the product in an emergency
medical services setting, though, would require
using waivers of consent under the 1996 FDA
rule”(5). In this situation, Polyheme changed
the course of their study and in the process,
lost the informed consent that was originally
part of the study and cost the lives of many
patients who were unwillingly subject to the
study. While the study was eventually stopped,
it took a long time to end, and during that
time, many casualties occurred. To fix this, a
new government organization that performs
random reviews on ongoing studies should be
created. This solution would create incentives
for companies that sponsor research to stay on
track with the approved guidelines of the study
as well as terminate any studies that start being
unethical early in order to minimize casualties.
From the chart below (Figure 3), it is evident
that Polyheme resulted in more deaths than the
control during the two days for which data was

provided. Many of these unnecessary deaths
may be avoided if a government organization
conducting random reviews on ongoing
research could cut the study short. D
CONTACT NICK AWERTSCHENKO AT
NICHOLAS.A.AWERTSCHENKO.21@DARTMOUTH.
EDU
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